Total
0
Shares
Isracann (CSE:IPOT) to import cannabis from major Israeli manufacturer
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Fiore Cannabis (FIOR) announces a non-brokered private placement of up to 4,000,000 units at C$0.15 per unit for gross proceeds of C$600,000
  • Each unit in the private placement is comprised of one common share and one share purchase warrant
  • Each warrant equals one common share at an exercise price of $0.22 for a period of eighteen months
  • Proceeds will be used to fund expansion projects in the company's Nevada and California operations
  • Fiore Cannabis (FIOR) has been investing in the development of medical and recreational cannabis products since 2014
  • Fiore Cannabis is unchanged, trading at C$0.16 per share at 11:45 am ET

Fiore Cannabis (FIOR) announces a non-brokered private placement of up to 4,000,000 units at C$0.15 per unit for gross proceeds of C$600,000.

The private placement is expected to close on or about April 9, 2021.

Each unit in the private placement is comprised of one common share and one share purchase warrant.

Each warrant is exercisable into one common share at an exercise price of $0.22 for a period of eighteen months from the date of issuance.

The warrants are subject to an accelerated expiration if the trading price of the company's common shares closes at or above $0.50 per share for a period of ten consecutive trading days.

Securities issued in the private placement will be subject to a hold period of four months and one day.

Proceeds will be used to fund expansion projects in the company's Nevada and California operations and for general working capital purposes.

"All of us at Fiore are excited about the future of our company. We continue to receive strong investor support for the company's refreshed business strategy.

We have many milestones to achieve this year that will shape our company for years to come. This financing will enable us to move forward on several fronts right away to further sharpen the focus on our U.S. operations." said Erik Anderson, President and CEO of Fiore Cannabis.

Fiore Cannabis (FIOR) has been investing in the development of medical and recreational cannabis products since 2014.

Fiore Cannabis is unchanged, trading at C$0.16 per share at 11:45 am ET.

More From The Market Herald
Namaste Technologies (TSXV:N) provides corporate update

" True Leaf (CSE:MJ) signs first customer to path-to-market program

True Leaf Brands Inc. (MJ) has signed Backwoods BC Bud to its new path-to-market program for micro-cultivators.
Cannabix (CSE:BLO) ramps up beta testing of its THC Breath Analyzer

" Cannabix (CSE:BLO) ramps up beta testing of its THC Breath Analyzer

Cannabix Technologies (BLO) has announced plans to test its THC Breath Analyzer (THCBA) in a high-volume clinic in the northwestern US.
Next Green Wave (CSE:NGW) reports rising revenue throughout 2020

" Greenway Greenhouse Cannabis (CSE:GWAY) is now trading on the CSE

Greenway Greenhouse Cannabis (GWAY) commenced trading on the CSE at market open on September 21.
Icanic Brands (CSE:ICAN) raises $2 million from cannabis asset sale

" Icanic Brands (CSE:ICAN) raises $2 million from cannabis asset sale

Icanic Brands (ICAN) has raised US$2 million from the sale of its interest in a California cultivation facility.